CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...
Cipla Ltd is one of the leading pharmaceutical companies in India ... Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1500 products across wide range of th... We ...
Pharma major Cipla Ltd on Monday said it will invest about ZAR 900 million (nearly Rs 415 crore) in equity share capital of its South African arm Cipla Medpro ...
Cipla share price today: The pharma major reported a 49% increase ... However, a key risk for the company is the delay in approvals for niche products, which is holding back its growth potential ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Jan 28, 2025 14:20 Cipla Launches Asthma Screening App in India Cipla has launched a mobile application, CipAir, to aid in asthma screening in India, aiming to address the country's high asthma burden ...